NEI News

Cross-sectional images of retina from retinoschisin-deficient mice, untreated and treated with XLRS gene therapy.

The National Eye Institute (NEI) recently launched the first-ever human gene therapy trial for the vision disorder X-linked retinoschisis (XLRS). Researchers are conducting the trial at the National Institutes of Health Clinical Research Center in Bethesda, Maryland.

Posted on Apr 6, 2015
 If a study participant were instructed to pay attention to “scenes” and he was attending well, he would be shown the top image as a reward. As his attention lapsed, the middle and bottom images would be shown. The face in the photograph is that of the study’s first author, Megan deBettencourt, a doctoral candidate at the Princeton Neuroscience Institute.

People are bad at staying focused. We’ve all had our minds wander when we try to concentrate on a task that requires paying close attention but isn’t all that engaging. But a new NIH-funded study suggests that one’s capacity to stay focused can improve with real-time feedback.

Posted on Feb 18, 2015
  • Facts About Stargardt Disease

    Stargardt disease is an inherited disorder of the retina – the tissue at the back of the eye that senses light.

  • NEI Audacious Goals Initiative

    The AGI is catalyzing research that will enable the restoration of vision through regeneration of the retina.

  • Join Our Healthy Vision Month Thunderclap!

    A Thunderclap allows large numbers of people and organizations to share the same message at the same time across their social media platforms.

  • Eye Health Infographics

    Use these graphics to share information quickly and clearly. Topics include AMD, cataract, glaucoma, diabetic retinopathy, low vision and more.

  • NIH Big Data to Knowledge (BD2K) initiative

    Enabling biomedical scientists to capitalize more fully on large, complex, and diverse datasets.